Bayer HealthCare Patent Term Extension Exhibits D-G
Summary
Bayer HealthCare submitted exhibits D-G to FDA in connection with a patent term extension application under docket FDA-2026-E-4532. The exhibits constitute supporting documentation for the extension request and have been filed in the regulatory docket for public access. No FDA action or determination is reflected in this filing.
About this source
Every FDA document on regulations.gov, the federal rulemaking portal. This is where the agency posts variances, advisory committee meeting notices, draft guidance for comment, citizen petition responses, and procedural rules that do not get a separate Federal Register slot. Around 240 a month. FDA's heavy regulations.gov use means tracking only the Federal Register misses a meaningful chunk of what the agency does day-to-day. Watch this if you manufacture devices, submit IND or NDA applications, run a lab, or advise sponsors on FDA process. GovPing publishes each posting with the docket, document type, division (CDER, CDRH, CFSAN), and comment window where one applies.
What changed
Bayer HealthCare filed exhibits D-G with FDA as part of a patent term extension application. The exhibits represent supporting materials for the extension request and have been formally entered into the regulatory record. This is a submission document, not an FDA action or determination.
Affected parties submitting patent term extension applications to FDA should ensure all required exhibits are filed in the correct docket format. Competitors monitoring patent expiration timelines should review filed exhibits for information that may affect their product launch planning.
Archived snapshot
Apr 27, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Related changes
Get daily alerts for Regs.gov: Food and Drug Administration
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from FDA.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when Regs.gov: Food and Drug Administration publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.